据了解，国仪量子自成立以来专注于高端科学仪器的研发，面向量子科技、材料科学、化学化工、生物 医药、先进制造等多个领域，向全球范围内的高校及科研院所、企业提供科技前沿探索所需的高端科学 仪器装备、以增强型量子传感器为代表的核心关键器件以及解决方案。公司IPO于2025年12月10日获得 受理，当年12月19日进入问询阶段。 北京商报讯（记者 王蔓蕾）2月25日晚间，上交所官网显示，国仪量子技术（合肥）股份有限公司（以 下简称"国仪量子"）科创板IPO对外披露首轮审核问询函回复。 在首轮审核问询函中，公司控股股东和实际控制人、技术来源和研发能力、营业收入等情况遭到追问。 本次冲击上市，国仪量子拟募集资金约11.69亿元，扣除发行等费用后，拟按照轻重缓急投资高端科学 仪器产业化项目、量子技术发展研究院建设项目、应用中心网络建设项目。 ...

Core Viewpoint - Guoyi Quantum Technology (Hefei) Co., Ltd. has entered the inquiry stage for its IPO on the Sci-Tech Innovation Board, focusing on high-end scientific instrument development and quantum technology applications [1] Company Overview - Guoyi Quantum specializes in the research and development of high-end scientific instruments, targeting multiple fields including quantum technology, materials science, chemical engineering, biomedicine, and advanced manufacturing [1] - The company provides high-end scientific instrument equipment and core key components, such as enhanced quantum sensors, to global universities, research institutions, and enterprises [1] IPO Details - The IPO application was accepted on December 10, 2025, with the company aiming to raise approximately 1.169 billion yuan [1] - After deducting issuance costs, the funds will be allocated to high-end scientific instrument industrialization projects, the establishment of a quantum technology research institute, and the construction of an application center network [1]

Core Viewpoint - Guoyi Quantum Technology (Hefei) Co., Ltd. is seeking to go public on the Sci-Tech Innovation Board (STAR Market) and has recently had its IPO materials accepted by the exchange [1] Company Overview - Guoyi Quantum is focused on the research and development of high-end scientific instruments, providing equipment and solutions for various fields including quantum technology, materials science, chemical engineering, biomedicine, and advanced manufacturing [5] - The company has delivered products to over 80 985/211 universities and more than 150 research institutes, with notable clients including Tsinghua University, Peking University, and industry leaders like BOE, BYD, and CATL [5] Leadership and Shareholding - The company is controlled by He Yu and Rong Xing, who together hold 34.87% of the voting rights. He Yu serves as the Chairman and General Manager, while Rong Xing is a board member [1][3] - He Yu's salary for 2024 is reported to be 692,800 yuan, which is relatively low compared to other executives [4] - Hillhouse Capital is a significant shareholder, holding 22,044,400 shares, which accounts for 6.12% of the total share capital before the IPO [4] Financial Performance - The company's projected revenues from 2022 to the first half of 2025 are 151 million yuan, 400 million yuan, 501 million yuan, and 171 million yuan, respectively. The net profit after deducting non-recurring items is expected to be negative for all periods, with figures of -168 million yuan, -169 million yuan, -104 million yuan, and -73.94 million yuan [5] - The company plans to raise 1.169 billion yuan through its IPO [6]

Core Viewpoint - Guoyi Quantum Technology (Hefei) Co., Ltd. has submitted its IPO application to the Sci-Tech Innovation Board, which has been accepted by the exchange [1] Group 1: Company Overview - Guoyi Quantum is controlled by He Yu and Rong Xing, who together hold 34.87% of the voting rights [1] - He Yu serves as the Chairman and General Manager, while Rong Xing is a board member [1] - The company focuses on the research and development of high-end scientific instruments, providing solutions and key components for various fields including quantum technology, materials science, and biomedicine [5] Group 2: Leadership Background - He Yu, born in 1992, is a PhD student at the University of Science and Technology of China and has held various managerial positions since 2013 [3] - Rong Xing, born in 1983, is also a PhD from the University of Science and Technology of China and has been involved in academia and research since 2011 [3] Group 3: Compensation Structure - He Yu's salary for 2024 is set at 692,800 yuan, which is relatively low compared to other executives [4] - Other executive salaries include Zhang Wei at 1,727,300 yuan and Cao Feng at 2,322,600 yuan [4] Group 4: Shareholder Information - Hillhouse Capital is a notable shareholder, holding 22,044,400 shares, which accounts for 6.12% of the total share capital before the IPO [4] Group 5: Financial Performance - The company's projected revenues from 2022 to the first half of 2025 are 151 million yuan, 400 million yuan, 501 million yuan, and 171 million yuan respectively [6] - The net profit after deducting non-recurring items is projected to be negative for the same period, with figures of -168 million yuan, -169 million yuan, -104 million yuan, and -73.94 million yuan [6] Group 6: IPO Details - The company plans to raise 1.169 billion yuan through the IPO [7]

Core Viewpoint - Guoyi Quantum Technology (Hefei) Co., Ltd. is planning to go public on the Sci-Tech Innovation Board, with rapid revenue growth but has not yet achieved profitability [1][4]. Group 1: Company Overview - Guoyi Quantum was established in 2016 and focuses on the research and development of high-end scientific instruments, providing essential equipment and solutions for quantum technology, materials science, chemical engineering, biomedical fields, and more [2]. - The company's actual controllers are He Yu and Rong Xing, who indirectly control 34.87% of the voting rights through various entities [2]. Group 2: Financial Performance - The company has shown significant revenue growth, with a compound annual growth rate (CAGR) of 81.94% from 2022 to 2024, although it has incurred losses during this period [4][7]. - Revenue figures for the years 2022 to 2025 (first half) are as follows: 151.50 million, 399.62 million, 501.47 million, and 171.21 million [4]. - The company expects to narrow its net profit loss significantly by 2025 and potentially achieve profitability by 2026 [7]. Group 3: Customer Base and Market Challenges - The customer base is relatively dispersed, with the top five customers contributing a decreasing percentage of total revenue from 26.62% in 2022 to 13.41% in the first half of 2025 [8][11]. - The high unit price and long lifespan of the products (5 to 10 years) result in low short-term repurchase rates from the same customers, complicating market expansion and customer maintenance [11]. - The industry is highly competitive, with established international firms holding significant market share, posing challenges for Guoyi Quantum in terms of brand recognition and product performance [11].

Core Viewpoint - Guoyi Quantum Technology (Hefei) Co., Ltd. is planning to go public on the Sci-Tech Innovation Board, with rapid revenue growth but has not yet achieved profitability. The company expects to narrow its losses significantly by 2025 and potentially achieve profitability by 2026 [1][5]. Group 1: Financial Performance - The company has experienced a compound annual growth rate (CAGR) of over 80% in revenue from 2022 to 2024, with revenues of 151.50 million yuan, 399.62 million yuan, 501.47 million yuan, and 171.21 million yuan for the respective years [5][8]. - Despite the revenue growth, the company reported net losses of 168.29 million yuan, 169.32 million yuan, 104.24 million yuan, and 73.94 million yuan during the same period, indicating ongoing financial challenges [5][8]. - The company anticipates a significant reduction in net losses by 2025 and expects to achieve profitability in 2026, with cumulative unabsorbed losses gradually decreasing [5][8]. Group 2: Business Model and Market Position - Guoyi Quantum focuses on the research and development of high-end scientific instruments, serving a diverse clientele including universities, research institutes, and enterprises across various fields such as quantum technology, materials science, and biomedical applications [1][8]. - The customer base is relatively dispersed, with the top five customers contributing only 26.62%, 24.62%, 17.02%, and 13.41% to the main business revenue from 2022 to mid-2025, indicating a low concentration of sales [8][11]. - The high price and long lifespan of the products (5 to 10 years) result in low short-term repeat purchases from the same customers, posing challenges in market expansion and customer maintenance [8][11]. Group 3: Competitive Landscape - The industry is characterized by intense competition, with international instrument manufacturers holding a dominant market position due to their historical advantages, scale, financial strength, and brand recognition [8][11]. - Guoyi Quantum is currently in a catch-up position against these international giants, facing challenges in product performance, stability, and market penetration [8][11]. - The company must continue to innovate and improve product performance and cost-effectiveness to maintain its competitive edge and avoid a decline in market position and revenue [8][11].

Core Viewpoint - Guoyi Quantum Technology (Hefei) Co., Ltd. has received acceptance for its IPO on the Sci-Tech Innovation Board, focusing on high-end scientific instrument development for various fields including quantum technology and biomedicine since its establishment in December 2016 [1] Group 1: Company Overview - Guoyi Quantum aims to provide high-end scientific instruments to global universities and research institutions, adhering to the philosophy of "Creating Instruments for the Nation" [1] - The actual controllers of the company, He Yu and Rong Xing, hold a combined 34.87% voting rights, with both being PhD graduates from the University of Science and Technology of China [1] Group 2: Financial Performance - The company's revenue for the reporting period (2022 to 2025) is projected to grow from 151 million to 501 million, with a compound annual growth rate of 81.94% [2] - Despite revenue growth, the company has not yet achieved profitability, with net profits projected to improve significantly by 2025 and expected to turn positive in 2026 [2] - Cumulative R&D investment over the last three years amounts to 361 million, representing 34.29% of total revenue [2] Group 3: Cash Flow and Management - The company has consistently reported negative net cash flow from operating activities, although the outflow has been decreasing over time [3] - Key management personnel have seen salary increases during the reporting period, with total compensation rising from 4.19 million to 5.01 million [3] Group 4: Client Base and Accounts Receivable - The company serves a diverse range of domestic and international clients, with the top five clients contributing a decreasing percentage of total revenue, from 26.62% to 13.41% [3] - Accounts receivable have increased significantly, with the balance reaching 1.47 billion by mid-2025, representing 86.08% of revenue for that period [3] Group 5: IPO and Fundraising - The company plans to raise approximately 1.169 billion for high-end scientific instrument projects, quantum technology research, and application center network construction [4]

Core Viewpoint - Guoyi Quantum Technology (Hefei) Co., Ltd. has received acceptance for its IPO on the Sci-Tech Innovation Board, focusing on high-end scientific instrument development across various fields including quantum technology and biomedicine [1] Company Overview - Guoyi Quantum specializes in the research and development of high-end scientific instruments, providing essential equipment and solutions for advanced scientific exploration to universities, research institutions, and enterprises globally [1] - The company is controlled by Hefei Sikun, which holds 27.2% of the shares, while the actual controllers, He Yu and Rong Xing, collectively control 34.87% of the voting rights [1] IPO Details - The company aims to raise approximately 1.169 billion yuan through the IPO, which will be allocated to high-end scientific instrument industrialization projects, the establishment of a quantum technology research institute, and the construction of an application center network [1]